Showing 1 - 7 results of 7 for search 'N. V. Trofimova', query time: 0.02s Refine Results
  1. 1
    Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use

    Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use by N. V. Trofimova, I. S. Preobrazhenskaya

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Development of small and medium-sized business sector in the Republic of Bashkortostan

    Development of small and medium-sized business sector in the Republic of Bashkortostan by E. R. Mamleeva, N. V. Trofimova, M. Yu. Sazykina

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Scientific potential of the region as a key factor of socio-economic development (by the example of the Republic of Bashkortostan)

    Scientific potential of the region as a key factor of socio-economic development (by the example of the Republic of Bashkortostan) by E. R. Mamleeva, N. V. Trofimova, L. V. Bolotova

    Published 2024-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Spatial compression: analysis and approaches to assessment (by the example of the republic of Bashkortostan)

    Spatial compression: analysis and approaches to assessment (by the example of the republic of Bashkortostan) by E. R. Mamleeva, M. Yu. Sazykina, N. V. Trofimova

    Published 2023-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Development of industrial infrastructure in the regions of the Russian Federation

    Development of industrial infrastructure in the regions of the Russian Federation by N. V. Trofimova, E. R. Mamleeva, M. Yu. Sazykina

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS­-CoV-­2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)

    Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS­-CoV-­2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28) by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, D. M. Los, O. V. Osipkina, A. Yu. Braga, A. A. Kovalev, A. V. Molchanova, N. V. Trofimova, O. S. Pershenkova, B. S. Yaroshevich, M. N. Mirge

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial

    Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, K. S. Korsak, O. V. Osipkina, A. V. Molchanova, A. A. Kovalev, D. M. Los, A. A. Ziatskov, A. S. Shaforost, M. N. Yatsuk, A. Yu. Braga, N. V. Trofimova, A. M. Dronina, E. L. Gasich, V. A. Gorbunov, A. Ev. Hancharou

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: